Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Bank Leumi (TASE: LUMI) led the market today, falling 1.02% on the day's biggest trading turnover. Bank Hapoalim (TASE: POLI) fell 1.37%, Mizrahi Tefahot Bank fell 0.53% and Israel Discount Bank (TASE ...
Analysts had forecast earnings of 70 cents per share ex-items for the Israel-based company on revenue of $4.13 billion, LSEG I/B/E/S data showed. Teva noted that in the fourth-quarter of 2023 its ...
1 Day TEVA -0.75% DJIA 0.16% S&P 500 0.24% Health Care/Life Sciences -0.28% ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened the reporting season for Israeli companies by publishing its fourth quarter and full year 2024 financial results.
SaverOne 2014 Ltd. Teva, a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE ...
Parents and activists say that the state is delaying switching Bedouin schools from dangerous generators to solar panels ...
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results